Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Cash from Investing Activities (2020 - 2024)

Opus Genetics has reported Cash from Investing Activities over the past 8 years, most recently at $1.2 million for Q4 2024.

  • Quarterly Cash from Investing Activities changed N/A to $1.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Sep 2025, changed N/A year-over-year, with the annual reading at $1.2 million for FY2024, N/A changed from the prior year.
  • Cash from Investing Activities was $1.2 million for Q4 2024 at Opus Genetics, up from -$100000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $1.2 million in Q4 2024 and troughed at -$100000.0 in Q4 2021.
  • The 3-year median for Cash from Investing Activities is $539000.0 (2020), against an average of $549666.7.
  • The largest YoY upside for Cash from Investing Activities was 118.55% in 2021 against a maximum downside of 118.55% in 2021.
  • A 3-year view of Cash from Investing Activities shows it stood at $539000.0 in 2020, then crashed by 118.55% to -$100000.0 in 2021, then skyrocketed by 1310.0% to $1.2 million in 2024.
  • Per Business Quant, the three most recent readings for IRD's Cash from Investing Activities are $1.2 million (Q4 2024), -$100000.0 (Q4 2021), and $539000.0 (Q4 2020).